Joel Greenblatt’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-30,100
Closed -$1.16M – 1914
2026
Q2
$1.16M Buy
+30,100
New +$917K ﹤0.01% 1315
2023
Q4
– Sell
-5,527
Closed -$212K – 1379
2023
Q3
$212K Buy
+5,527
New +$125K ﹤0.01% 1221

Other funds holding IMVT

Joel Greenblatt's IMVT Position: Q3 2026 in Review

Joel Greenblatt sold out of Immunovant (IMVT) in Q3 2026, closing a stake of 30,100 shares — an estimated $1.16M sold.

Joel Greenblatt first reported a position in IMVT in Q3 2023 and held it in 2 quarters. The position peaked at $1.16M in Q2 2026. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Joel Greenblatt reported no remaining Immunovant position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 30,100 Immunovant shares in Q3 2026, an estimated $1.16M.
  • Joel Greenblatt first reported a position in Immunovant in Q3 2023 and held it in 2 quarters.
  • Joel Greenblatt's Immunovant position peaked at $1.16M in Q2 2026.
  • 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.